Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Jenscare Scientific Co. Ltd. Class H ( (HK:9877) ) has provided an announcement.
Jenscare Scientific Co., Ltd. has announced the appointment of Mr. Pan Fei as its new Chief Executive Officer, effective January 15, 2025. Mr. Pan, who has been with the company since 2021, brings over 15 years of experience in corporate management and investment banking, particularly in the healthcare sector. This leadership change is part of the company’s strategy to further its internationalization and global commercialization efforts. The former CEO, Mr. Lv Shiwen, will continue to serve as an Executive Director and chairman of the Board, ensuring continuity in the company’s governance.
More about Jenscare Scientific Co. Ltd. Class H
Jenscare Scientific Co., Ltd. is a healthcare-focused company based in China, engaged in the development of medical technologies and solutions. The company is part of a group with a strategic focus on global commercialization and expanding its market presence in the international healthcare industry.
YTD Price Performance: 18.65%
Average Trading Volume: 996,640
Technical Sentiment Consensus Rating: Hold
Current Market Cap: HK$2.31B
For a thorough assessment of 9877 stock, go to TipRanks’ Stock Analysis page.
